UroGen Pharma Ltd.

UR8.F·Frankfurt·Healthcare
Compare
30.69−0.98 (−3.09%)today
As of Oct 22, 8:03 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close31.67
Open30.69
Day range—
52-week range14.5042.90
Off day high0.00%
Off 52-week high−28.46%
Volume20.00
Avg. volume (3M)15.00
Market cap1.50B
EPS (TTM)-1.69
Forward P/E-8.36
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.58
Shares outstanding48.88M
Short interest—
Earnings dateAug 5, 2026
Analyst target—
Profit margin−51.73%

Against its peers

Compare in full ›
UR8.F PHM.VI QURE CGON OCUL RARE
Market cap 1.50B 1.22B 1.60B 5.54B 1.45B 1.57B
P/E (TTM) — 23.5 — — — —
Forward P/E -8.4 — -7.8 -20.7 -4.5 70.7
Price/book -12.7 4.9 4.9 5.4 2.8 -5.4
Dividend yield — 1.43% — — — —
1-year change +112.55% −7.71% −61.76% +48.26% −43.36% −52.66%
Today −3.09% +1.07% +1.85% +0.48% +2.01% +0.19%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to UR8.F's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Pharma Mar, S.A.PHM.VI · Biotechnology 1.22B 70.80 +1.07%
uniQure N.V.QURE · Biotechnology 1.60B 23.11 +1.85%
CG Oncology, Inc.CGON · Biotechnology 5.54B 62.54 +0.48%
Ocular Therapeutix, Inc.OCUL · Biotechnology 1.45B 6.61 +2.01%
Ultragenyx Pharmaceutical Inc.RARE · Biotechnology 1.57B 15.95 +0.19%
Syndax Pharmaceuticals, Inc.SNDX · Biotechnology 1.21B 13.57 +3.19%
Puma Biotechnology, Inc.PBYI · Biotechnology 581.24M 11.26 +3.30%
Aura Biosciences, Inc.AURA · Biotechnology 669.93M 6.46 0.00%

What visitors to UR8.F's page also look at.

Company Mkt cap Price Today
Ceryvyn Therapeutics Ltd.UKJ0.F 6.29M 0.0046 0.00%
BIOCRYST PHARMACEUTICALS INC. RBO1.F 1.73B 6.76 −2.12%
Omeros Corp.3O8.F 1.03B 14.25 −1.38%
China Shineway Pharmac.Grp LtdRC1S.F 604.32M 0.8000 −1.84%
Consun Pharmaceutic.Group Ltd.RC1P.F 1.39B 1.6600 −2.92%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All UR8.F news ›
Seeking Alpha·Negative

UroGen Pharma: An Emerging GARP Stock

UroGen Pharma (URGN) stock dipped 30% after a 208% rally—see why Zusduri’s launch, reimbursement, and patents could fuel growth. - UroGen Pharma has pulled back 30% after a 208% rally, driven by Zusduri’s strong launch as the only approved…

Stock Titan·

UroGen Pharma CFO sells 2,202 shares to cover taxes

UroGen Pharma Ltd. (URGN) develops RTGel-based therapies for urothelial and specialty cancers, including Jelmyto and ZUSDURI for non-surgical tumor ablation. - [Form 4] UroGen Pharma Ltd. Insider Trading Activity UroGen Pharma CFO sells…

From articles in the 4Search news index.

In the news

10mentions in 30 days
10with it in the headline
Positivesentiment

Mentioned with

United Therapeutics9Urogen Pharma Ltd.6Weiss Ratings6HC Wainwright5Needham & Company Llc5Wall Street Zen5Zacks Research Pasqal5Acrivon Therapeutics4

People in the coverage

Danessa Lincoln9Mitch Edgeman9Kim Johansen8Marketbeat8Michael Walen7Benzinga6

Themes

Healthcare9Uthr8Urgn7Consensus6Ratings6Cartesian Therapeutics5EPS5HC Wainwright5

Most coverage from

  1. themarketsdaily.com7
  2. seekingalpha.com1
  3. stocktitan.net1
  4. tradingview.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.